SCHEMBL19797979

SCHEMBL19797979

CCOC(=O)C(C)(CN)c1cccc(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 4/20 0.46
POLB P06746 2/20 0.45
LMNA P02545 3/20 0.42
MAPT P10636 2/20 0.40
KIF11 P52732 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
FBP1 P09467 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.38
GLA P06280 1/20 0.38
RIPK1 Q13546 1/20 0.37
PIN1 Q13526 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
CASP1 P29466 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
CNR2 P34972 1/20 0.37
JAK2 O60674 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21656355 0.87 KDM4E (0.46) KCNN4POLBMAPTSMN1; SMN2ALDH1A1
SCHEMBL3671448 0.83 PIN1 (0.49) KCNN4POLBMAPTSMN1; SMN2PIN1
SCHEMBL17420423 0.81 POLB (0.51) KCNN4POLBLMNAMAPTSMN1; SMN2
Hydrochloric Acid SCHEMBL17825610 0.81 MAPT (0.43) KCNN4LMNAMAPTSMN1; SMN2TDP1
SCHEMBL5004403 0.79 POLB (0.47) KCNN4POLBLMNAMAPTSMN1; SMN2
Hydrochloric Acid SCHEMBL31084739 0.78 XPO1 (0.39) MAPTALDH1A1CNR2
SCHEMBL17999493 0.78 POLB (0.43) KCNN4POLBLMNAMAPTSMN1; SMN2
SCHEMBL19797977 0.78 MAPT (0.47) KCNN4POLBLMNAMAPTSMN1; SMN2
SCHEMBL17999316 0.77 MAPT (0.46) KCNN4POLBLMNAMAPTSMN1; SMN2
SCHEMBL29145552 0.76 POLB (0.47) KCNN4POLBLMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180022747-A1 Factor IXa Inhibitors MERCK SHARP & DOHME CORP. (US) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180022747-A1 Factor IXa Inhibitors F9, TFPI, F12 KCNN4 1710/4885POLB 3869/4885LMNA 1124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.